Official French SARS-CoV-2 guidelines for cancer patients, a triage solution with precision medicine.

IF 2.7 Q3 ONCOLOGY

Colorectal Cancer Pub Date : 2020-05-01 DOI:10.2217/crc-2020-0018

Juan Manuel O'Connor, Federico Esteso, Matías Chacón

引用次数: 1

Abstract

One of the early guidelines to protect cancer patients against the novel coronavirus (SARS-CoV-2) was developed in early March by the French High Council for Public Health at the request of the French Health Ministry. These guidelines were prepared by a representative group of medical oncologists and radiation oncologists, working in both academic and private practice. The results of this initiative were published by You et al. in Lancet Oncology on 25 March [1]. In addition to ethical and practical considerations for the management of cancer patients in the context of the COVID-19 pandemic, these official guidelines provide helpful recommendations [1]:

查看原文本刊更多论文

法国官方针对癌症患者的SARS-CoV-2指南，一种精准医学的分诊解决方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Colorectal Cancer ONCOLOGY-

自引率

0.00%

发文量

期刊介绍： Colorectal cancer is a major cause of morbidity and mortality, particularly in the developed world. Risk factors for colorectal cancer are on the rise in many countries; populations are aging, and obesity and diabetes are increasing. National screening programs are helping to detect cancer while it is still curable; however, colorectal cancer remains the third leading cause of cancer deaths in the USA and options are still limited for those with more advanced disease. Consequently, colorectal cancer is a major research priority for government, pharmaceutical companies and non-profit organizations. Research into diagnosis and optimum treatment of the disease is progressing rapidly, with new advances reported every day. Colorectal Cancer presents reviews, analysis and commentary. on all aspects of colorectal cancer.